BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33410475)

  • 21. Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma.
    Soufir N; Lacapere JJ; Bertrand G; Matichard E; Meziani R; Mirebeau D; Descamps V; Gérard B; Archimbaud A; Ollivaud L; Bouscarat F; Baccard M; Lanternier G; Saïag P; Lebbé C; Basset-Seguin N; Crickx B; Cave H; Grandchamp B
    Br J Cancer; 2004 Jan; 90(2):503-9. PubMed ID: 14735200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy.
    Star P; Goodwin A; Kapoor R; Conway RM; Long GV; Scolyer RA; Guitera P
    Eur J Cancer; 2018 Mar; 92():48-53. PubMed ID: 29413689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma-specific survival.
    Chen K; Liu H; Liu Z; Bloomer W; Amos CI; Lee JE; Li X; Nan H; Wei Q
    Mol Carcinog; 2019 Nov; 58(11):2091-2103. PubMed ID: 31435991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
    van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
    J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival.
    Xu Y; Wang Y; Liu H; Shi Q; Zhu D; Amos CI; Fang S; Lee JE; Hyslop T; Li X; Han J; Wei Q
    Mol Carcinog; 2018 Jan; 57(1):22-31. PubMed ID: 28796414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular Metastasis of BRAF+ Cutaneous Malignant Melanoma.
    Gonzalez A; Miles JF; Khurshid GS
    Ophthalmol Retina; 2018 Jan; 2(1):71. PubMed ID: 31047306
    [No Abstract]   [Full Text] [Related]  

  • 27. Genome-wide linkage analysis of Swedish families to identify putative susceptibility loci for cutaneous malignant melanoma.
    Höiom V; Tuominen R; Hansson J
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1076-84. PubMed ID: 21901783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: A retrospective cohort study.
    Ipenburg NA; Lo SN; Vilain RE; Holtkamp LHJ; Wilmott JS; Nieweg OE; Thompson JF; Scolyer RA
    J Am Acad Dermatol; 2020 Apr; 82(4):910-919. PubMed ID: 31682859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline determinants of clinical outcome of cutaneous melanoma.
    Vogelsang M; Wilson M; Kirchhoff T
    Pigment Cell Melanoma Res; 2016 Jan; 29(1):15-26. PubMed ID: 26342156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Updated field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma: the MelGene database.
    Antonopoulou K; Stefanaki I; Lill CM; Chatzinasiou F; Kypreou KP; Karagianni F; Athanasiadis E; Spyrou GM; Ioannidis JPA; Bertram L; Evangelou E; Stratigos AJ
    J Invest Dermatol; 2015 Apr; 135(4):1074-1079. PubMed ID: 25407435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heritability and GWAS Studies for Monocyte-Lymphocyte Ratio.
    Lin BD; Willemsen G; Fedko IO; Jansen R; Penninx B; de Geus E; Kluft C; Hottenga J; Boomsma DI
    Twin Res Hum Genet; 2017 Apr; 20(2):97-107. PubMed ID: 28193307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer.
    Liu Y; Kheradmand F; Davis CF; Scheurer ME; Wheeler D; Tsavachidis S; Armstrong G; Simpson C; Mandal D; Kupert E; Anderson M; You M; Xiong D; Pikielny C; Schwartz AG; Bailey-Wilson J; Gaba C; De Andrade M; Yang P; Pinney SM; ; Amos CI; Spitz MR
    J Thorac Oncol; 2016 Jan; 11(1):52-61. PubMed ID: 26762739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiplex melanoma families are enriched for polygenic risk.
    Law MH; Aoude LG; Duffy DL; Long GV; Johansson PA; Pritchard AL; Khosrotehrani K; Mann GJ; Montgomery GW; Iles MM; Cust AE; Palmer JM; ; Shannon KF; Spillane AJ; Stretch JR; Thompson JF; Saw RPM; Scolyer RA; Martin NG; Hayward NK; MacGregor S
    Hum Mol Genet; 2020 Oct; 29(17):2976-2985. PubMed ID: 32716505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status.
    Helgadottir H; Tuominen R; Olsson H; Hansson J; Höiom V
    J Am Acad Dermatol; 2017 Nov; 77(5):893-901. PubMed ID: 28818438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment.
    Urist MM; Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA
    Ann Surg; 1984 Dec; 200(6):769-75. PubMed ID: 6508408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma Expression Genes Identified through Genome-Wide Association Study of Breslow Tumor Thickness.
    Fang S; Vaysse A; Brossard M; Wang Y; Deng D; Liu Q; Zhang P; Xu K; Li M; Feng R; Liu H; Dang Y; Chen W; Prieto V; Gershenwald JE; Ross MI; Matejka B; Malke J; Haydu LE; Reveille JD; Sui D; Bassett RL; Koshkina N; Avril MF; Lu M; Wei Q; Demenais F; Amos CI; Lee JE
    J Invest Dermatol; 2017 Jan; 137(1):253-257. PubMed ID: 27506587
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterization of melanoma susceptibility genes in high-risk patients from Central Italy.
    Pellegrini C; Maturo MG; Martorelli C; Suppa M; Antonini A; Kostaki D; Verna L; Landi MT; Peris K; Fargnoli MC
    Melanoma Res; 2017 Jun; 27(3):258-267. PubMed ID: 28146043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional annotation of melanoma risk loci identifies novel susceptibility genes.
    Fang S; Lu J; Zhou X; Wang Y; Ross MI; Gershenwald JE; Cormier JN; Wargo J; Sui D; Amos CI; Lee JE
    Carcinogenesis; 2020 Jun; 41(4):452-457. PubMed ID: 31630191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
    Potrony M; Puig-Butille JA; Ribera-Sola M; Iyer V; Robles-Espinoza CD; Aguilera P; Carrera C; Malvehy J; Badenas C; Landi MT; Adams DJ; Puig S
    Br J Dermatol; 2019 Jul; 181(1):105-113. PubMed ID: 30451293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRAF and epithelial-mesenchymal transition in primary cutaneous melanoma: a role for Snail and E-cadherin?
    Mitchell B; Leone DA; Feller JK; Yang S; Mahalingam M
    Hum Pathol; 2016 Jun; 52():19-27. PubMed ID: 26980024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.